BBP Among Health Care ETFs
End-of-day Nov 16, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.7% | −5.0% | −0.9% | −4.0% | +24.3% | +30.1% | +112.3% | +90.4% | +287.0% |
| Peer average | −1.5% | −3.2% | +4.0% | +1.6% | +19.6% | +25.3% | +73.9% | +24.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$61 of every $1,000 in BBP is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 6.11% | $610.57 | 35K | $8.1M |
| 2 | XERSXeris Biopharma | Healthcare | 3.23% | $323.00 | 258K | $4.3M |
| 3 | OMEROmeros | Healthcare | 2.71% | $271.29 | 201K | $3.6M |
| 4 | VSTMVerastem | Healthcare | 2.71% | $271.16 | 428K | $3.6M |
| 5 | IOVAIovance Biotherapeutics | Healthcare | 2.46% | $246.34 | 430K | $3.3M |
| 6 | KNSAKiniksa Pharmaceuticals International | Healthcare | 2.44% | $244.41 | 34K | $3.3M |
| 7 | ADMAADMA Biologics | Healthcare | 2.12% | $212.43 | 214K | $2.8M |
| 8 | BGNEBeOne Medicines | — | 2.07% | $207.16 | 6,628 | $2.8M |
| 9 | REGNRegeneron Pharmaceuticals | Healthcare | 2.05% | $204.62 | 2,863 | $2.7M |
| 10 | ZLABZai Lab | Healthcare | 2.01% | $200.94 | 103K | $2.7M |
| 11 | HALOHalozyme Therapeutics | Healthcare | 1.91% | $190.80 | 25K | $2.5M |
| 12 | RIGLRigel Pharmaceuticals | Healthcare | 1.83% | $183.21 | 53K | $2.4M |
| 13 | GILDGilead Sciences | Healthcare | 1.76% | $176.14 | 14K | $2.3M |
| 14 | ROIVRoivant Sciences | Healthcare | 1.75% | $175.35 | 58K | $2.3M |
| 15 | IRWDIronwood Pharmaceuticals | — | 1.75% | $175.03 | 480K | $2.3M |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 6.11% |
| 2 | XERS | Xeris Biopharma | 3.23% |
| 3 | OMER | Omeros | 2.71% |
| 4 | VSTM | Verastem | 2.71% |
| 5 | IOVA | Iovance Biotherapeutics | 2.46% |
| 6 | KNSA | Kiniksa Pharmaceuticals International | 2.44% |
| 7 | ADMA | ADMA Biologics | 2.12% |
| 8 | BGNE | BeOne Medicines | 2.07% |
| 9 | REGN | Regeneron Pharmaceuticals | 2.05% |
| 10 | ZLAB | Zai Lab | 2.01% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2017 | Dec 27, 2017 | $0.0723 |
| Dec 21, 2015 | Dec 29, 2015 | $0.40 |